Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.38 - $22.5 $271,604 - $16.1 Million
714,748 New
714,748 $278,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $23.4 $46,187 - $1.48 Million
63,271 Added 9.51%
728,351 $514,000
Q2 2022

Aug 15, 2022

BUY
$0.66 - $1.81 $3,432 - $9,412
5,200 Added 0.79%
665,080 $538,000
Q1 2022

May 11, 2022

BUY
$1.27 - $2.47 $7,759 - $15,091
6,110 Added 0.93%
659,880 $1.1 Million
Q4 2021

Feb 11, 2022

SELL
$2.21 - $3.22 $3,821 - $5,567
-1,729 Reduced 0.26%
653,770 $1.53 Million
Q3 2021

Nov 12, 2021

BUY
$2.8 - $3.72 $150,598 - $200,080
53,785 Added 8.94%
655,499 $2.04 Million
Q2 2021

Aug 11, 2021

SELL
$2.61 - $4.17 $290,104 - $463,499
-111,151 Reduced 15.59%
601,714 $2.02 Million
Q1 2021

May 13, 2021

SELL
$2.91 - $4.32 $71,711 - $106,457
-24,643 Reduced 3.34%
712,865 $2.22 Million
Q4 2020

Feb 09, 2021

BUY
$2.15 - $3.5 $320,726 - $522,112
149,175 Added 25.36%
737,508 $2.03 Million
Q3 2020

Nov 12, 2020

SELL
$2.77 - $6.17 $138,214 - $307,864
-49,897 Reduced 7.82%
588,333 $1.68 Million
Q2 2020

Aug 12, 2020

BUY
$0.87 - $3.13 $141,963 - $510,740
163,176 Added 34.35%
638,230 $1.98 Million
Q1 2020

May 06, 2020

BUY
$0.73 - $1.91 $228,460 - $597,753
312,960 Added 193.07%
475,054 $451,000
Q3 2019

Nov 07, 2019

BUY
$0.47 - $1.05 $2,677 - $5,981
5,697 Added 3.64%
162,094 $76,000
Q2 2019

Aug 12, 2019

BUY
$0.65 - $2.12 $84,744 - $276,397
130,376 Added 501.04%
156,397 $183,000
Q1 2019

May 14, 2019

SELL
$1.54 - $2.01 $8,945 - $11,676
-5,809 Reduced 18.25%
26,021 $49,000
Q4 2018

Feb 11, 2019

BUY
$1.22 - $2.41 $38,832 - $76,710
31,830 New
31,830 $51,000
Q2 2018

Aug 06, 2018

SELL
$2.75 - $3.85 $195,522 - $273,731
-71,099 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.5 - $4.47 $9,173 - $11,715
2,621 Added 3.83%
71,099 $248,000
Q4 2017

Feb 09, 2018

BUY
$3.29 - $5.03 $225,292 - $344,444
68,478
68,478 $293,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.